BIOGEN INC
BIOGEN INC
Share · US09062X1037 · BIIB · 789617 (XNAS)
Overview Financial Indicators
133,04 USD
1,49 % 1,95 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 22:35

Current Prices from BIOGEN INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BIIB
USD
06.06.2025 22:35
133,04 USD
130,36 USD
+2,05 %
XETR: XETRA
XETRA
IDP.DE
EUR
06.06.2025 15:35
116,40 EUR
115,25 EUR
+1,00 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 2,50 % 13,88 % -9,73 % -15,68 % -41,66 % -56,63 %

Company Profile for BIOGEN INC Share

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Invested Funds

The following funds have invested in: BIOGEN INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
1.672,34
Percentage (%)
3,92 %
Fund
iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)
Vol. in million
19.346,92
Percentage (%)
1,34 %
Fund
iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)
Vol. in million
17,23
Percentage (%)
1,29 %
Fund
iShares Edge MSCI World Multifactor UCITS ETF EUR Hedged (Acc)
Vol. in million
59,46
Percentage (%)
0,88 %
Fund
iShares Refinitiv Inclusion and Diversity UCITS ETF
Vol. in million
329,28
Percentage (%)
0,84 %

Company Data

Name BIOGEN INC
Company Biogen Inc.
Symbol BIIB
Website https://www.biogen.com
Primary Exchange XNAS NASDAQ
WKN 789617
ISIN US09062X1037
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Christopher A. Viehbacher
Market Capitalization 15 Mrd.
Country United States of America
Currency USD
Employees 7,6 T
Address 225 Binney Street, 02142 Cambridge
IPO Date 2000-01-03

Stock Splits

Date Split
18.01.2001 3:1
21.12.1999 2:1

ID Changes

Date From To
12.11.2003 IDPH BIIB

Ticker Symbols

Name Symbol
Frankfurt IDP.F
NASDAQ BIIB
XETRA IDP.DE

More Shares

Investors who BIOGEN INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
CARREFOUR 23/31 MTN
CARREFOUR 23/31 MTN Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
ILLUMINA INC
ILLUMINA INC Share
INTEL CORP
INTEL CORP Share
LB.HESS.-THR. E0515B 025
LB.HESS.-THR. E0515B 025 Bond
MICROSOFT CORP
MICROSOFT CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
RESTAURANT BRANDS INTL
RESTAURANT BRANDS INTL Share
STEICO SE
STEICO SE Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025